Page last updated: 2024-09-02

fingolimod hydrochloride and Cardiac Conduction Defect

fingolimod hydrochloride has been researched along with Cardiac Conduction Defect in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ando, K; Cao, X; Harada, T; Izumi-Nakaseko, H; Kato, K; Kitahara, K; Nakamura, Y; Ninomiya, T; Ohara, H; Sugiyama, A; Suzuki, K; Yagi, Y	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Cardiac Conduction Defect

Article	Year
Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolimod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation. Toxicology and applied pharmacology, 2014, 11-15, Volume: 281, Issue:1 Topics: Animals; Atrioventricular Block; Brugada Syndrome; Cardiac Conduction System Disease; Fingolimod Hydrochloride; Guinea Pigs; Heart Conduction System; HEK293 Cells; Humans; Immunosuppressive Agents; Long QT Syndrome; Male; Receptors, Lysosphingolipid	2014

Article

Year

Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolimod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation.

Toxicology and applied pharmacology, 2014, 11-15, Volume: 281, Issue:1

Topics: Animals; Atrioventricular Block; Brugada Syndrome; Cardiac Conduction System Disease; Fingolimod Hydrochloride; Guinea Pigs; Heart Conduction System; HEK293 Cells; Humans; Immunosuppressive Agents; Long QT Syndrome; Male; Receptors, Lysosphingolipid

2014